VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2013

Oct 29, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2013-10-25

Reporting Person: Silva Paul M (SVP & Corp Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-25	Common Stock	M	1125	$48.74	Acquired	12875	Direct
2013-10-25	Common Stock	S	1025	$76.56	Disposed	11850	Direct
2013-10-25	Common Stock	S	100	$78.29	Disposed	11750	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-10-25	Stock Option (right to buy)	$48.74	M	1125	Disposed	2022-07-24	Common Stock (1125)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	169	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F2: Open market sales reported on this line occurred at a weighted average price of $76.56 (range $76.22 to $76.97).

F3: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4: The option vests in 16 quarterly installments from 07/25/2012.